Wed, April 12, 2023
Tue, April 11, 2023
Mon, April 10, 2023
Fri, April 7, 2023
Thu, April 6, 2023

Ashwani Verma Maintained (UTHR) at Strong Buy with Decreased Target to $310 on, Apr 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-310-on-apr-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ashwani Verma of UBS, Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Decreased Target from $330 to $310 on, Apr 10th, 2023.

Ashwani has made no other calls on UTHR in the last 4 months.



There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 0 agree with Ashwani's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Ashwani


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, February 23rd, 2023
  • Jessica Fung of "JP Morgan" Maintained at Buy with Increased Target to $280 on, Thursday, February 23rd, 2023
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $300 on, Wednesday, January 11th, 2023

Publication Contributing Sources